[Effect of inoculation with Calmette-Guerin bacillus on the development of Ehrlich ascites tumor in the mouse].

No abstract is available for this paper.

• Publication year

  1959

• Venue

  Comptes rendus des seances de la Societe de biologie et de ses filiales

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 13800817
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Effect of stimulation of the reticuloendothelial system by inoculation of the Calmette-Guerin bacillus on the development of the atypical Guerin T-S epithelioma in the rat].

  1959cited by this paper

• BCG and cancer (first of two parts).

  2010cites this paper
• Immunostimulating agents: what next? A review of their present and potential medical applications.

  1996cites this paper
• Some aspects of the macrophage-cancer relationship.

  1993cites this paper
• High-dose inhibition and low-dose enhancement of murine sarcoma growth exhibited by BCG vaccine.

  1991cites this paper
• Antitumor effect of agrimoniin, a tannin of Agrimonia pilosa Ledeb., on transplantable rodent tumors.

  1987cites this paper
• Effect of activation or blockade of the phagocytic system on the antitumor activity of grifolan.

  1986cites this paper
• Need for immunologic stimulators during immunosuppression produced by major cancer surgery.

  1985cites this paper
• Early cellular responses in the peritoneal cavity of mice to antitumor immunomodulators.

  1984cites this paper
• [Comparative kinetics of spleen cell-mediated antibody-dependent cytotoxic activity in mice treated with BCG or Mycobacterium smegmatis].

  1983cites this paper
• BCG-induced macrophages as suppressor cells.

  1983cites this paper
• Modulation of cell-mediated alloimmunity by BCG. II. Induction of specific, nonadherent, non-T-killer cells by BCG and alloantigen.

  1982cites this paper
• Modulation of cell-mediated alloimmunity by BCG. I. Antagonism and potentiation of immunosuppression caused by cytarabine.

  1982cites this paper
• [Effects of lipopolysaccharide (E. coli) and OK-432, a Streptococcus preparation, on the hepatic drug-metabolizing system in mice (author's transl)].

  1981cites this paper
• Induction of delayed-type hypersensitivity and antitumor immunity by systemic BCG.

  1980cites this paper
• Growth inhibition of murine tumours by Streptococcus faecalis: effects of systemic, intralesional & prophylactic inoculations.

  1980cites this paper
• The immunological activities of bacterial peptidoglycans.

  1980cites this paper
• Facilitation and/or inhibition of growth of sarcoma-180 ascites tumour by BCG: effects of BCG on tumour cell membrane.

  1980cites this paper
• Induction of cytotoxic peritoneal exudate cells by T-cell immune adjuvants of the beta(1 leads to 3) glucan-type lentinan and its analogues.

  1980cites this paper
• Active non-specific immunotherapy of experimental tumours.

  1980cites this paper
• Modulation of immunity by bacillus Calmette-Guérin (BCG).

  1979cites this paper
• [Medical mangement of Crohn's disease (author's transl)].

  1979cites this paper
• [Influence of reintervention by the bacillus of Calmette and Guérin (BCG) on the nonspecific resistance of the mouse to Schistosoma mansoni (author's transl)].

  1979cites this paper
• Role of endogenous interferon in the anti‐tumor effect of poly I·C and statolon as demonstrated by the use of anti‐mouse interferon serum

  1978cites this paper
• [Effect of Bacillus Callmette Guerin (BCG) on the receptivity of nude mice to Schistosoma mansoni].

  1978cites this paper
• Antitumor activity of mycobacterial glycolipid A1

  1978cites this paper
• Splenic and Hassall's corpuscles modifications following injection of fresh BCG in the guinea-pig.

  1977cites this paper
• High resistance induced by young live Bacillus Calmette-Guérin (BCG) to Schistosoma mansoni infection in mice.

  1977cites this paper
• [Inflammation and host resistance against tumours. I. Delayed growth of Lewis tumour and inhibition of lung metastasis in mice having an inflammatory reaction distant from the inoculation site of tumour cells (author's transl)].

  1977cites this paper
• Inhibition of tumor growth by the peptidoglycan from Bacillus megaterium.

  1977cites this paper
• Effect of Corynebacterium parvum, methanol-extraction residue of BCG, and levamisole on macrophage random migration, chemotaxis, and pinocytosis.

  1977cites this paper
• Selective mobilization of specifically cytotoxic T-lymphocytes at sites of inflammation in relation to BCG-induced resistance to implants of syngeneic sarcoma in mice.

  1977cites this paper
• Enhancement of nonspecific immunity to bacterial infection by cord factor (6,6'-trehalose dimycolate).

  1977cites this paper
• [Modifications by BCG of the mortality of the irradiated mouse].

  1976cites this paper
• Nonspecific resistance against infection with Salmonella typhi and Salmonella typhimurium induced in mice by cord factor (trehalose-6,6'-dimycolate) and its analogues

  1976cites this paper
• Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.

  1976cites this paper
• Treatment of the mouse Lewis tumor by the association of radiotherapy and immunotherapy with Bacillus Calmette-Guérin.

  1976cites this paper
• Current questions on the tumour-associated antigens of chemically-induced tumours II. In search of practical uses.

  1976cites this paper
• A cytochemical study of the in vitro interaction between normal and activated mouse peritoneal macrophages and tumor cells.

  1976cites this paper
• Study of the mechanism of Corynebacterium Parvum anti‐tumour activity. I. Protective effect on the growth of two syngeneic tumours

  1976cites this paper
• Modulation of the immune response by BCG: a review.

  1976cites this paper
• Increased resistance to virus infections of mice inoculated with BCG (Bacillus calmette-guérin).

  1976cites this paper
• BACILLUS CALMETTE‐GUÉRIN CONTACT IMMUNOTHERAPY OF LOCAL AND METASTATIC DEPOSITS OF RAT TUMORS *

  1976cites this paper
• Bcg therapy of pleural and peritoneal growth of transplanted rat tumours

  1975cites this paper
• Histologic reactions of the thymus, spleen, liver and lymph nodes to intravenous and subcutaneous BCG injections.

  1975cites this paper
• Comparison between macrophage activation and enhancement of nonspecific resistance to tumors by mycobacterial immunoadjuvants.

  1975cites this paper
• Immunopotentiation with BCG: dimensions of a specific antitumor response.

  1975cites this paper
• Enhancement of immunity against murine syngeneic tumors by a fraction extracted from non-pathogenic mycobacteria.

  1975cites this paper
• New experimental and clinical data on leukaemia immunotherapy.

  1975cites this paper
• The effect of Corynebacterium parvum on the structure and function of the lymphoid system in mice.

  1974cites this paper
• Suppression of Growth of Ehrlich Ascites Tumor Cells in Mice by Trehalose-6, 6′ -Dimycolate (Cord Factor) and BCG

  1974cites this paper
• Lasting rejection of mammary adenocarcinoma cell tumors in DBA-2 mice with intratumor injection of killed Corynebacterium parvum.

  1974cites this paper
• [Inhibition of neoplasms by stimulation of immunity. Experimental aspects (with review of the questions discussed)].

  1974cites this paper
• Non-specific immunostimulation in bronchogenic cancer.

  1974cites this paper
• Effects of BCG and two of its phenotypes on Ehrlich tumor.

  1974cites this paper
• Bacillus Calmette-Guerin in the treatment of neoplastic disease.

  1974cites this paper
• Letter: Cytotoxicity after B.C.G. infection.

  1974cites this paper
• Immunopotentiation with BCG. I. Immune response to different strains and preparations.

  1973cites this paper
• BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy.

  1973cites this paper
• Antitumor activity of anaerobic Corynebacterium isolated from the human bone marrow.

  1973cites this paper
• An experimental screening for "systemic adjuvants of immunity" applicable in cancer immunotherapy.

  1973cites this paper
• [The immunity mechanisms, for or against the cancer patient?].

  1973cites this paper
• Preliminary results of nonspecific immunotherapy for lung cancer.

  1973cites this paper
• Protective effects of BCG and other bacteria against neoplasia in mice and hamsters.

  1973cites this paper
• Treatment of malignant melanoma by intratumoral injection of BCG.

  1973cites this paper
• BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.

  1973cites this paper
• Bacteriological survey of anaerobic Corynebacterium in human bone marrow and blood.

  1973cites this paper
• [Active immunotherapy in acute lymphoid leukemia in children. Influence of several factors on the results].

  1973cites this paper
• Factors influencing the effect of an adjuvant on the growth of solid isogeneic tumors.

  1972cites this paper
• Five-year survival rate of gastric cancer patients treated by gastrectomy, large dose of mitomycin-C, and-or allogeneic bone marrow transplantation.

  1972cites this paper
• [BCG and experimental leukemia].

  1972cites this paper
• Attempts at immunotherapy of 100 patients with acute lymphoid leukemia: some factors influencing results.

  1972cites this paper
• Immunological effects of BCG in malignant melanoma: two modes of administration compared.

  1972cites this paper
• Immunological approaches of leukaemia treatment.

  1972cites this paper
• Preliminary result of a new protocol for the active immunotherapy of acute lymphoblastic leukaemia: inhibition of the immunotherapeutic effect by Vincristine or Adamantadine.

  1971cites this paper
• [Study of the action of an immunostimulin associated with anaerobic Corynebacteria in human and experimental neoplasms].

  1971cites this paper
• [Role of the macrophages in nonspecific immunity].

  1971cites this paper
• Lentinan, a New Immuno-accelerator of Cell-mediated Responses

  1971cites this paper
• Stimulating influence of bacillus Calmette-Guérin on immunity to polyoma tumors and spontaneous leukemia.

  1971cites this paper
• Lymphocyte Transformation in Patients with Acute Lymphoblastic Leukaemia

  1971cites this paper
• Recent Attempts at Immunotherapy

  1971cites this paper
• Effect of pertussis antigen and cyclophosphamide on myeloma tumor.

  1970cites this paper
• [Response of the RES to Mycobacterium tuberculosis (BCG) and Corynebacterium parvum in mice of different strains].

  1970cites this paper
• Active immunotherapy for acute lymphoblastic leukaemia.

  1969cites this paper
• Active immunotherapy in treatment of acute leukaemia

  1969cites this paper
• [Protective role of B.C.G. in experimental schistosomiasis due to S. mansoni].

  1969cites this paper
• [Attempts at active non-specific immunotherapy using formolized Corynebacterium parvum].

  1969cites this paper
• The antitumor action of bacterial extract. I. Suppression of mouse ascites tumors by the treatments with extracts of E. coli.

  1969cites this paper
• Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.

  1969cites this paper
• Approaches to the immunological treatment of cancer in man.

  1969cites this paper
• [Demonstration of the efficacy of active immunotherapy in human acute lymphoblastic leukemia].

  1968cites this paper
• [Effects of B.C.G. on the hepatic catalase activity in mouse. Relation between the reticuloendothelial system and the resistance against grafted AKR leukemia].

  1968cites this paper
• [Treatment of acute lymphoblastic leukemia in children during remission with a sequential chemotherapy followed by an active immunotherapy trial].

  1968cites this paper
• [The protective effect of Corynebacterium parvum against grafts of AKR leukemia. Relation with hepatic catalase activity and the phagocytic function of the reticulo-endothelial system].

  1968cites this paper
• Stimulation of the reticuloendothelial system in tumor-bearing rats.

  1968cites this paper
• Increased nonspecific resstance to malaria produced by administration of killed Corynebacterium parvum.

  1967cites this paper
• Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts.

  1966cites this paper
• Influence of host conditions upon the growth pattern of transplanted tumors.

  1966cites this paper
• [Action of a BCG inoculation in F1 hybrids of the phenomenon of syngenic preference demonstrated by certain isologous tumors].

  1966cites this paper
• Inhibition of Tumour Growth by Administration of Killed Corynebacterium parvum

  1966cites this paper
• Influence of bacille Calmette-Guérin infection on polyoma in hamsters and mice.

  1966cites this paper